| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgements
|
|
|
|
19 |
S5 |
p. v18-v19
|
article
|
| 2 |
author index
|
|
|
|
19 |
S5 |
p. v169-v171
|
article
|
| 3 |
basic science and bench to bedside (lab)
|
|
|
|
19 |
S5 |
p. v130-v132
|
article
|
| 4 |
Biomarkers in drug development
|
Zwierzina, H.
|
|
|
19 |
S5 |
p. v33-v37
|
article
|
| 5 |
breast cancer, advanced
|
|
|
|
19 |
S5 |
p. v133-v135
|
article
|
| 6 |
breast cancer, early
|
|
|
|
19 |
S5 |
p. v136-v138
|
article
|
| 7 |
Cancer and pregnancy
|
Pentheroudakis, G.
|
|
|
19 |
S5 |
p. v38-v39
|
article
|
| 8 |
Cancer stem cells
|
Mackenzie, I.C.
|
|
|
19 |
S5 |
p. v40-v43
|
article
|
| 9 |
chest tumors
|
|
|
|
19 |
S5 |
p. v139-v140
|
article
|
| 10 |
colorectal cancer
|
|
|
|
19 |
S5 |
p. v141-v144
|
article
|
| 11 |
Current role of surgery and multimodal treatment in localized gastric cancer
|
van de Velde, C.J.H.
|
|
|
19 |
S5 |
p. v93-v98
|
article
|
| 12 |
developmental therapeutics
|
|
|
|
19 |
S5 |
p. v145-v146
|
article
|
| 13 |
ECLU 2008 Disclosures
|
|
|
|
19 |
S5 |
p. v174
|
article
|
| 14 |
Editorial Board
|
|
|
|
19 |
S5 |
p. ii-iv
|
article
|
| 15 |
ESMO Conference Lugano (ECLU) 2008 Officers and Organization
|
|
|
|
19 |
S5 |
p. v20
|
article
|
| 16 |
ESMO Educational and Scientific Activities
|
|
|
|
19 |
S5 |
p. v11-v12
|
article
|
| 17 |
ESMO Educational Committee
|
|
|
|
19 |
S5 |
p. v6-v10
|
article
|
| 18 |
ESMO Fellowship Program
|
|
|
|
19 |
S5 |
p. v13-v15
|
article
|
| 19 |
ESMO Foundation
|
|
|
|
19 |
S5 |
p. v17
|
article
|
| 20 |
ESMO Membership Services
|
|
|
|
19 |
S5 |
p. v1
|
article
|
| 21 |
Eso symposium: breast cancer inyoung women
|
|
|
|
19 |
S5 |
p. v129
|
article
|
| 22 |
European Society for Medical Oncology – Committees
|
|
|
|
19 |
S5 |
p. v2-v5
|
article
|
| 23 |
Genetic counseling: what is important to know in your clinic
|
Pithers, A.
|
|
|
19 |
S5 |
p. v81-v83
|
article
|
| 24 |
genitourinary tumors
|
|
|
|
19 |
S5 |
p. v147-v148
|
article
|
| 25 |
geriatric oncology
|
|
|
|
19 |
S5 |
p. v149
|
article
|
| 26 |
gynecological cancer
|
|
|
|
19 |
S5 |
p. v150-v151
|
article
|
| 27 |
head and neck cancer
|
|
|
|
19 |
S5 |
p. v152
|
article
|
| 28 |
health services and public health
|
|
|
|
19 |
S5 |
p. v153
|
article
|
| 29 |
hematological malignancies
|
|
|
|
19 |
S5 |
p. v154-v156
|
article
|
| 30 |
HPV vaccines and cervical cancer
|
Bosch, F.X.
|
|
|
19 |
S5 |
p. v48-v51
|
article
|
| 31 |
Introduction from Prof. Nicholas Pavlidis, Greece ECLU 2008 working Group Chair
|
|
|
|
19 |
S5 |
p. v21
|
article
|
| 32 |
Long-term survivorship after cancer: how far have we come?
|
Fosså, S.D.
|
|
|
19 |
S5 |
p. v25-v29
|
article
|
| 33 |
neuroendocrine tumors and cup
|
|
|
|
19 |
S5 |
p. v157
|
article
|
| 34 |
Neuro-oncology
|
|
|
|
19 |
S5 |
p. v158
|
article
|
| 35 |
new diagnostics
|
|
|
|
19 |
S5 |
p. v159
|
article
|
| 36 |
New insights into molecular mechanisms of haematological malignancies
|
Fey, M.F.
|
|
|
19 |
S5 |
p. v59-v62
|
article
|
| 37 |
New treatments in multiple myeloma: beyond optimal treatment
|
Harousseau, J.-L.
|
|
|
19 |
S5 |
p. v68-v70
|
article
|
| 38 |
Nutritional issues in anti-cancer treatment
|
Vandebroek, A.J.V.
|
|
|
19 |
S5 |
p. v52-v55
|
article
|
| 39 |
palliative care
|
|
|
|
19 |
S5 |
p. v160
|
article
|
| 40 |
Pathology: is it still necessary?
|
Viale, G.
|
|
|
19 |
S5 |
p. v111-v112
|
article
|
| 41 |
Perioperative or postoperative therapy for resectable gastric cancer?
|
Labianca, R.
|
|
|
19 |
S5 |
p. v99-v102
|
article
|
| 42 |
Preoperative therapy: what, when and for whom?
|
von Minckwitz, G.
|
|
|
19 |
S5 |
p. v113-v116
|
article
|
| 43 |
Prevention and screening
|
|
|
|
19 |
S5 |
p. v161
|
article
|
| 44 |
Progress in radiotherapy for early breast cancer
|
Bartelink, H.
|
|
|
19 |
S5 |
p. v117-v121
|
article
|
| 45 |
psycho-oncology
|
|
|
|
19 |
S5 |
p. v162
|
article
|
| 46 |
Recent advances in adjuvant systemic therapy for early-stage breast cancer
|
Bedard, P.L.
|
|
|
19 |
S5 |
p. v122-v127
|
article
|
| 47 |
Recent therapeutic advances in hematological malignancies: dealing with treatment-related complications
|
Ludwig, H.
|
|
|
19 |
S5 |
p. v71-v78
|
article
|
| 48 |
Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma
|
Schmitz, N.
|
|
|
19 |
S5 |
p. v63-v67
|
article
|
| 49 |
sarcoma
|
|
|
|
19 |
S5 |
p. v163
|
article
|
| 50 |
subject index
|
|
|
|
19 |
S5 |
p. v172-v173
|
article
|
| 51 |
supportive care
|
|
|
|
19 |
S5 |
p. v164-v165
|
article
|
| 52 |
Table of Contents
|
|
|
|
19 |
S5 |
p. v
|
article
|
| 53 |
The clinical implications of genetics. BRCA1- and BRCA2-positive: how do I proceed? Implications for ovarian cancer prevention
|
Verheijen, R.H.M.
|
|
|
19 |
S5 |
p. v84-v86
|
article
|
| 54 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
19 |
S5 |
p. v1
|
article
|
| 55 |
The implications of genetics in colorectal cancer
|
Mecklin, J.-P.
|
|
|
19 |
S5 |
p. v87-v90
|
article
|
| 56 |
The treatment of advanced gastric cancer: current strategies and future perspectives
|
Cervantes, A.
|
|
|
19 |
S5 |
p. v103-v107
|
article
|
| 57 |
Translating genetic pathways to protein networks for cancer sub-typing
|
Eltze, E.
|
|
|
19 |
S5 |
p. v44-v47
|
article
|
| 58 |
upper gastrointestinal tumors
|
|
|
|
19 |
S5 |
p. v166-v168
|
article
|
| 59 |
Young Oncologists
|
|
|
|
19 |
S5 |
p. v16
|
article
|
Journal description